No Data
BriaCell 2024 SABCS Spotlight Poster to Showcase Positive Overall Survival Data Across All Patient Subtypes in Metastatic Breast Cancer
BriaCell Provides Update to Its Board of Directors
Express News | Briacell Provides Update to Its Board of Directors
BriaCell Therapeutics Shares Are Trading Higher After the Company Announced It Dosed the First Patient in Its Phase 1/2 Study of Bria-OTS.
Briacell Therapeutics Has Dosed The First Patient In Its Phase 1/2 Study To Evaluate The Safety And Efficacy Of Bria-OTS, Briacell's Personalized Next Generation Immunotherapy
BriaCell Announces First Patient Dosed With Bria-OTS in Metastatic Breast Cancer Study
No Data
No Data
Willy 5150 : could be, but it's better to focus on Price Action. Atm looks like a good stock to swing trade as it looks like it's bottoming out. Just my silly and humble opinion.